Australia cyclone hits Rio Tinto iron production

|

Published 01-APR-2019 14:47 P.M.

|

1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Mining giant Rio Tinto said on Monday its Australian iron ore production has been curtailed by a tropical cyclone that hit last month and it would be unable to fulfil some contracts.

In a statement, the world's second-biggest mining firm said operations in the Pilbara region of Western Australia were getting back to normal after Cyclone Veronica struck as a category 3 storm on March 24, but some damage had been found.

"Initial inspections uncovered some damage to the Cape Lambert A port facility," the company said, announcing that it had "declared force majeure on certain contracts and is working with its customers to minimise any disruption in supply".

Coupled with a fire at a Cape Lambert facility earlier this year, the cyclone "will result in a loss of approximately 14 million tonnes of production in 2019".

Rio's total output from the Pilbara for this year was expected to be between around 338 and 350 million tonnes.

Iron ore prices have been on the rise of late, as Brazilian miner Vale trimmed production estimates and amid concerns about the impact of Cyclone Veronica.

arb/grk/jah

© Agence France-Presse



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X